For decades, dementia, especially Alzheimer’s disease, was treated as untouchable. Families watched loved ones fade, doctors could offer only reassurance and coping strategies, and research seemed to ...
The FDA on Monday approved an experimental drug that aims to slow the progression of Alzheimer's disease, despite the fact that a key FDA panel late last year said that questions remain about its ...
The pursuit of a cure for Alzheimer's disease is becoming an increasingly competitive and contentious quest, with recent ...
Nov 3 (Reuters) - U.S. health experts this week will decide whether to recommend approval for Biogen Inc's (BIIB.O), opens new tab Alzheimer's drug, which could become the first new treatment for the ...
CAMBRIDGE, Mass. -- Biogen Inc. said Tuesday it will seek federal approval for a medicine to treat early Alzheimer's disease, a landmark step toward finding a treatment that can alter the course of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback